ASHP Seeks Clarification on Federal Guidance for Pharmacies on Reproductive Health

Published: July 14, 2022

ASHP today warned the White House that language included in the Biden administration's new guidance for pharmacies on access to comprehensive reproductive healthcare services may have the unintended effect of limiting pharmacists' authority and clinical decision-making, to the detriment of patients.

In a letter to President Biden, ASHP Chief Executive Officer Paul W. Abramowitz noted that the guidance prohibits discrimination involving the making of determinations about the suitability of prescribed medications or advising patients how to take medications. The letter asks the Department of Health and Human Services to clarify that the guidance is not intended to limit the pharmacist–patient relationship or pharmacists' clinical decision-making. The letter also seeks guidance on the interaction of state and federal laws regarding reproductive health.

Posted July 14, 2022

Advance Your Professional Development

View All

Medication Safety Certificate

Certification is a process used by health care organizations worldwide to accurately assess their level of performance in relation to established standards and to implement ways to continuously improve.
Enroll Today
New Practitioner Hero Image

Basic in Cardiology Pharmacy Certificate

This self-guided, online learning activity will provide 29 hours of ACPE continuing education for pharmacists, incorporating recorded presentations and skill-focused activities.
Enroll Today